Reprogramming obesity: New drug aims to treat the underlying causes

Details of a new drug that aims to treat the underlying causes of obesity were presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup